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Low plasma and renal tissue levels of L-arginine in rats with
obstructive nephropathy
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Low plasma and renal tissue levels of L-arginine in rats with obstructive
nephropathy. Rats with bilateral ureteral obstruction (BUO) of 24 hours
duration had significantly lower plasma levels of L-arginine than at
baseline (P < 0.0001), but no significant changes occurred in sham-
operated rats (SOR). In contrast, rats with bilateral nephrectomy had
greater plasma levels of L-arginine four hours (P < 0.03) and 24 hours
(not significant) after nephrectomy than at baseline. Total body irradi-
ation prior to obstruction prevented the decrease in plasma levels of
L-arginine in rats with BUO but had no effect on these values in SOR.
Renal tissue levels of L-arginine were 20% lower in rats with BUO than
in SOR. Total body irradiation prior to BUO resulted in greater renal
tissue levels of L-arginine than occurred in nonirradiated rats with BUO
(P < 0.002). Total body irradiation did not affect renal tissue levels of
L-arginine in SOR. Excretion of reactive nitrogen intermediates in urine
(U1), indicative of L-arginine metabolism through the nitric oxide
pathway, was lower in rats with BUO than in SOR (P < 0.0001).
Proximal tubules from rats with BUO synthesized less L-arginine than
those from SOR (P < 0.02). The results indicate that: (1) decreased
levels of L-arginine in plasma and renal tissue of rats with BUO
correlate with leukocyte infiltration of the kidney, and (2) decreased
synthesis of L-arginine occurs in proximal tubules of rats with BUO
when compared to tubules from SOR. We suggest that the changes in
plasma levels of L-arginine seen in rats with BUO are not due to its
utilization by invading macrophages or to uremia, but rather to an
undefined signal from immune cells to inhibit synthesis of L-arginine in
proximal renal tubules and in extrarenal structures.
Leukocyte infiltration of the kidneys of rats with bilateral
ureteral obstruction (BUO) is detected as early as four hours
after the onset of obstruction, peaks at about 24 hours and
correlates with increased production of metabolites of arachi-
donic acid known to decrease effective renal plasma flow
(ERPF) and glomerular filtration rate (GFR) [1—3]. Activated
macrophages metabolize L-arginine to reactive nitrogen inter-
mediates (RNI) including nitrite, nitrate and nitric oxide (NO)
[4]. During the course of hemodynamic studies delineating the
effect of NO on renal function and blood pressure in rats with
BUO [5], we noted that plasma levels of L-arginine, the
precursor of NO, were significantly lower in rats with BUO
than in sham-operated rats (SOR) and that administration of
L-arginine to rats with BUO ameliorated the decrease in GFR
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and the elevation in systemic blood pressure observed in these
rats [5]. These findings and the fact that the kidneys, particu-
larly proximal tubules, are the major site of synthesis of
circulating L-arginine [6] led us to postulate that the decreased
activity of the NO system in rats with BUO was due, at least in
part, to decreased availability of the substrate for its synthesis.
By logical extension of this hypothesis, leukocytes invading the
kidney may play a role in the hemodynamic alterations seen in
obstructive nephropathy not only by contributing to increased
production of thromboxane A2 [1] and leukotrienes [2], but also
by mediating changes in plasma and renal tissue levels of
L-arginine, which in turn may influence the balance between
vasoconstrictors and vasodilators in the setting of obstructive
nephropathy [7]. In the present study we examined the potential
role of leukocytes inifitrating the kidney in the changes in
plasma and renal tissue levels of L-arginine and in the excretion
of URN! seen in rats with BUO.
Methods
Animals
Studies were performed in 88 female Sprague Dawley rats
(mean weight 219 4 g) obtained from Sasco, Inc (Omaha,
Nebraska, USA) with free access to food (standard rat chow
with 22.5% protein, 1.42% L-arginine, Ralston Purina, St
Louis, Missouri, USA), and tap water. Female rats were used
because, in contrast to male rats, they exhibit a dietary intake
that closely matches their energy expenditure, thus preventing
excess caloric intake [8], and also because bladder catheteriza-
tion is easier in female than in male rats.
Bilateral ureteral obstruction and sham-operation were per-
formed as described previously [9]. Access to both food and
water was withheld from rats with BUO until the time of
experiments 24 hours later. Sham-operated rats were allowed
water but no food during the 24 hours time period prior to
study.
Bilateral nephrectomy was performed under ether anesthesia
through a small abdominal incision. The rats were allowed to
awake and returned to their cages until the time of studies
described below. These rats were allowed no food or water
after operation.
Clearance studies and blood pressure determinations were
performed after unilateral release of BUO as described previ-
ously [2, 3, 5, 7, 9]. Total body irradiation, a maneuver that
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effectively depletes bone marrow-derived leukocytes [2, 3], also
was performed as described previously [2].
Levels of L-arginine in plasma and renal tissue were deter-
mined by a tRNA method as described previously [10]. Briefly,
rats were lightly anesthetized with halothane and a 500 p1 blood
sample was obtained through the left femoral vein by using a
23-gauge needle and the volume replaced with the same amount
of normal saline. Blood was immediately centrifuged at 5000
rpm for five minutes and plasma was separated and stored at
—80°C for further determinations of amino acid levels. Renal
tissue was obtained with the rat under halothane anesthesia by
clamping the aorta above the renal arteries and perfusing the
kidneys in situ with 50 ml PBS (pH 7.4, 37°C). At this time the
kidneys were decapsulated in situ, severed from the hilus,
snap-frozen in liquid nitrogen and stored at —80°C for further
determination of the amino acid content. Renal tissue levels of
L-arginine are expressed per g of protein measured by the
method of Lowry et al [11]. Nitrite and nitrate excretion in the
sterile urine obtained from rats that had clearance studies, and
release of nitrate and nitrite from proximal tubules were deter-
mined by the Griess reaction [12], as modified by Wu and
Brosnan [13].
Isolation of proximal tubules
Proximal tubule preparations were obtained using the method
of Vinay, Goagoux and Lemieux [14]. Utilizing these prepara-
tions we examined the ability of proximal tubules isolated from
five SOR and five rats with BUO to synthesize L-arginine.
Briefly, 24 hours after surgery, rats were lightly anesthetized
with sodium pentobarbital (50 mg/kg body wt, i.p.), and the
abdominal aorta was cannulated at the level of the bifurcation
and clamped above the renal arteries. Both kidneys were
perfused with ice-cold Krebs-Henseleit solution (KHS)(pH 7.4)
containing (mM): 115.5 NaCl, 4.7 KC1, 1.25 CaCl2-2H20, 1.18
KH2PO4, 10.0 Dextrose, 5.0 Hepes, 1.25 Mg504 and 27.5
NAHCO3, previously gassed at 20°C with 95% 02 and 5% CO2
for 30 minutes. After perfusion with KHS, the kidneys were
harvested, decapsulated, and cut sagittally, and the medulla
was separated from the cortex. Samples from the SOR were
pooled in one preparation and those obtained from BUO rats in
another. Each preparation was treated as follows. Renal corti-
cal tissue was sliced with a microtome and placed in 40 ml of
cold KHS, removed, washed three times with 60 ml of cold
KHS and resuspended in 20 ml of KHS containing 30 mg of
collagenase (Worthington Biochemical Corp, Freehold, New
Jersey, USA) and 1 ml of 10% bovine albumin. Cortical slices
were gassed with 95% 02 and 5% CO2 for two minutes and
placed in a shaking bath at 37°C for 45 minutes. At this time 60
ml of KHS were added and the whole suspension was filtered to
remove collagen fibers. After the suspension was washed three
times with 60 ml of cold KHS, the tissue was resuspended in 5%
albumin for five minutes and centrifuged for 30 seconds; the
supernatant was discarded. The preparations were resuspended
in 50% Percoll solution maintained at 4°C (previously gassed for
30 minutes with 95% 02 and 5% CO2 at room temperature) and
centrifuged at 15000 rpm for 30 minutes. Fraction IV of the
Percoll gradient was removed, resuspended and washed twice
in cold KHS and the tubules were resuspended in 500 p1 of
KHS and incubated for one hour at 37°C with KHS (500 p1) or
with a mixture of L-citrulline/L-aspartate (0.1/5.0 mmol) in 500
p1 KHS for 30 minutes. Incubations were terminated with 0.4
ml 30% perchloric acid and samples were kept at —80°C for
further determination of levels of L-arginine. Experiments were
performed in triplicate.
Experimental groups
Four experimental groups were studied.
Group I (N = 29). This group consisted of 10 SOR, 10 rats
with BUO, 5 SOR with total body irradiation, and 4 BUO rats
with total body irradiation. Standard clearance studies were
performed in these animals, with determination of the excretion
of reactive nitrogen intermediates in the urine (URNI).
Group II (N = 23). Five SOR, 6 rats with BUO, 6 SOR that
underwent total body irradiation, and 6 BUO rats that under-
went total body irradiation comprised Group II. Plasma levels
of L-arginine were determined in these animals before and 24
hours after surgical procedures.
Group III (N = 26). This group consisted of 9 SOR, 7 rats
with BUO, 5 rats with bilateral nephrectomy with plasma
obtained four hours after the surgical procedure, and 5 rats that
had bilateral nephrectomy with plasma obtained 24 hours later.
Plasma levels of L-arginine were determined in these animals
before and after the surgical procedures.
Group IV (N = 10). This group consisted of 5 SOR and 5 rats
with BUO. Proximal tubules from animals in this group were
prepared as described above for study of the basal production
of L-arginine and the effect on L-arginine production of the
L-arginine precursor, L-citrulline, together with L-aspartate,
added to the tubule suspension.
Other measurements
Inulin was determined using the anthrone method [15] and
PAH was measured by a modification of the method of Smith et
al [16].
Calculations and statistics
Clearances of inulin and PAH were calculated using a stan-
dard formula. For each rat, values of three consecutive clear-
ance periods were averaged. Values obtained in SOR are
expressed per one kidney. Determinations of L-arginine in
plasma and renal tissue and excretion of URNI were performed
in duplicate, and the results averaged. Production and/or re-
lease of L-arginine into the media by proximal tubule prepara-
tions is expressed in nmol of L-arginine per mg of protein per 30
minutes. Urine excretion of RN! is expressed per p1 of urine
flow. Intragroup comparisons were performed by a paired
t-test, and intergroup comparisons by one way analysis of
variance (ANOVA) with Bonferroni's correction. Differences
were considered significant when P < 0.05.
Results
Table 1 shows the results of renal function studies and blood
pressure determinations in Group I animals: SOR, rats with
BUO, and rats that underwent either sham operation or BUO
combined with total body irradiation. As expected, values for
GFR and ERPF were significantly lower after unilateral release
of obstruction of 24 hours duration than in sham-operated rats.
In rats with BUO, GFR was 26% and ERPF was 23% of the
values obtained per one kidney in SOR. In rats with BUO that
had total body irradiation, a maneuver that decreases the
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SOR
N=10
SOR + TB!
N=5 BUON=10 BUON + TB!=4
Urine flow 30.3 3.6 19.8 2.5 54.2 95a 41.6 5.3
piimin
GFR mi/mini 6.69 0.51 7.13 0.41 1.76 0.l7a 2.81 028b
kg body wt
ERPF mi/mini 21.2 1.40 ND 4.81 0.73a 7.76 023b
kg body wt
MAP mm Hg 122 2 120 1 155 4 167 3
Group! comprised sham-operated rats and rats with bilateral ureteral
obstruction, with or without total body irradiation.
Results are expressed as mean standard error of the mean. Values
in sham-operated rats are expressed per one kidney. Abbreviations are:
SOR, sham-operated rats; TB!, total body irradiation; BUO, bilateral
ureteral obstruction; GFR, glomerular filtration rate; ERPF, effective
renal plasma flow; MAP, mean arterial pressure; ND, not determined.
aP < 0.05 when compared to SOR
b p < 0.05 when compared to BUO
formation of bone marrow-derived leukocytes [2, 3], values for
GFR and for ERPF were 60% (P <0.005) and 62% (P < 0.03)
greater than in nonirradiated rats with BUO. Total body irradi-
ation did not significantly affect GFR in SOR when compared to
nonirradiated controls; ERPF could not be compared in these
two groups, since it was not determined in SOR given total
body irradiation due to a laboratory accident. Rats with BUO
also had significantly greater urine flow and mean arterial
pressure than SOR. Total body irradiation did not affect those
measurements in SOR or rats with BUO when compared to
their respective nonirradiated controls.
Values for excretion of URN! in rats of Group I are depicted
in Figure 1. Total excretion of measurable URNI (nitrite plus
nitrate) was significantly Less in rats with BUO than in SOR
(0.92 0.18 vs. 6.96 1.20 nmol/min, P < 0.0001). Total body
irradiation decreased excretion of URN! by 60% in SOR when
compared to nonirradiated sham-operated controls (P < 0.04).
Total body irradiation did not significantly affect excretion of
URN! in rats with BUO when compared to nonirradiated BUO
controls. Determination of the urinary excretion of these RN!
showed an uneven distribution of NO3'- versus NO2—: sham-
operated rats excreted 96% of RNI as NO3'- versus 4% as
NO2—, and rats with unilateral release of BUO of 24 hours
duration excreted 84% of RN! as NO3'- versus 16% as NO2—.
Since extrarenal nitrite entering the circulation reacts immedi-
ately with oxihemoglobin forming methemoglobin and nitrate
[17], this pathway results in nitrate excretion in the urine. Thus,
urinary excretion of nitrite may indicate primarily renal metab-
olism of NO. The biological significance of these findings, if
any, remains to be elucidated.
Plasma and renal tissue levels of L-arginine in rats of Group
II obtained at baseline and 24 hours after sham-operation,
bilateral ureteral obstruction, sham operation preceded by total
body irradiation, and bilateral ureteral obstruction preceded by
total body irradiation are summarized in Table 2. Basal plasma
levels of L-arginine in the four groups of rats were not signifi-
cantly different from each other. In SOR, plasma levels of
L-arginine 24 hours after surgery were not significantly different
from those obtained at baseline. In contrast, in rats with BUO,
plasma levels of L-arginine were significantly lower 24 hours
BUO SOR+TBI BUO+TBI
Fig. 1. Urine excretion of reactive nitrogen intermediates (URN!) in
rats of Group I: sham-operated rats (SOR), rats with unilateral release
of bilateral ureteral obstruction (BUO), rats undergoing total body
irradiation (TB!) prior to SOR (SOR+ TB!), and rats undergoing TB! 48
hours prior to BUO (BUO+ TB!). Symbols are: (0) NO3; (0) NO2. The
excretion of RNI in the urine was significantly less in rats with BUO of
24 hours duration than in SOR. TB! significantly lowered these values
in SOR but did not significantly change them in rats with BUO.
0.00001 vs. SOR; **J) < 0.04 vs. SOR.
after ureteral ligation than at baseline (P < 0.0001). Rats that
had total body irradiation prior to BUO had plasma levels of
L-arginine after 24 hours of obstruction that were not signifi-
cantly different from baseline values, or from the pre- and
post-values obtained in SOR.
Renal tissue levels of L-arginine showed the same pattern as
plasma L-arginine levels (Table 2). Levels of L-arginine in renal
tissue were 20% lower in rats with BUO than in SOR. However,
this difference did not reach statistical significance. SOR with
total body irradiation had renal tissue levels of L-arginine not
significantly different than those values obtained in nonirradi-
ated SOR. In contrast, BUO rats with total body irradiation had
greater renal tissue levels of L-arginine than non-irradiated rats
with BUO (P < 0.002).
Since under normal circumstances the kidneys, and particu-
larly proximal tubules, are the most important site of synthesis
of circulating L-arginine for extrarenal use [61, we examined the
effect of uremia induced by bilateral nephrectomy versus the
effect of uremia induced by BUO of 24 hours duration on
plasma levels of this amino acid. Plasma levels of L-argimne in
SOR, rats with BUO and rats with bilateral nephrectomy
(Group III) are summarized in Table 3. Basal values obtained
prior to surgery or sham surgery in the four groups studied were
not significantly different from each other. Plasma levels of
L-arginine obtained 4 or 24 hours after sham-operation were not
significantly different from baseline values. Rats with BUO of
24 hours duration had plasma levels of L-arginine significantly
lower than at baseline. In contrast, rats with uremia induced by
bilateral nephrectomy had plasma levels of L-arginine signill-
cantly greater than at baseline four hours after surgery (P <
0.03). Rats with bilateral nephrectomy studied 24 hours after
surgery had plasma levels of L-arginine 33% greater than, but
not significantly different from, baseline values.
Table 1. Renal function and mean arterial pressure in rats of Group!
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Table 2. Plasma and renal tissue levels of L-arginine in rats of Group II
Number
of rats
L-arginine levels in plasma /SM L-arginine levels in tissue
p.mol/g protein after 24
hrBaseline After 24 hr P value
SOR 5 167.7 24.6 170.3 36.3 NS 2277 260
SOR + TBI 6 163.4 20.8 172.1 24.0 NS 2651 530
BUO 6 166.0 8.64 103.4 7.0 <0.0001 1817 380
BUO + TBI 6 179.7 24.8 155.1 28.8 NS 3698 499a,b
Group II contains sham-operated rats and rats with bilateral ureteral obstruction with or without total body irradiation.
Results are expressed as mean standard error of the mean. Abbreviations are: SOR, sham-operated rats; BUO, bilateral ureteral obstruction;
TBI, total body irradiation; NS, not significant. Total body irradiation was performed 48 hours prior to either sham-operated or BUO.
Determination of levels of L-arginine in renal tissue was performed in both kidneys per rat, the results were then averaged and the mean and
standard error of the mean calculated.
a P < 0.05 when compared to values obtained in kidneys from sham-operated ratsb p < 0.05 when compared to values obtained in kidneys from rats with BUO
Table 3. Plasma levels of L-arginine in rats of Group III
Group of rats N
L-argininc /SM Time of
study P valueBaseline Experimental
SOR 5 167.7 24.6 170.3 36.3 24 hr NS
SOR 4 147.7 27.4 118.0 25.6 4 hr NS
BUO 7 188.5 14,0 64.9 18.9 24 hr <0.004
Nephrectomized 5 158.7 21.0 371.2 76.6 4 hr <0.03
Nephrectomized 5 141.2 11.9 190.8 29.5 24 hr NS
Group II comprises sham-operated rats, rats with bilateral ureteral obstruction and nephrectomized rats
Results are expressed as mean standard error of the mean. Abbreviations are: SOR, sham-operated rats; BUO, bilateral ureteral obstruction;
NS, not significant.
Release of L-arginine from proximal tubules obtained from
SOR and from rats with BUO under basal conditions and in the
presence of physiological concentrations of L-citrulline and
pharmacological concentrations of L-aspartate (Group IV) is
shown in Figure 2. Proximal tubules isolated from SOR released
significantly more L-arginine than those obtained from rats with
BUO (P < 0.02). Addition of L-citrulline and L-aspartate
increased the synthesis of L-arginine by proximal tubules
isolated from rats with BUO to levels not significantly different
from basal values obtained in SOR, but significantly greater
than baseline levels in rats with BUO (P < 0.02). In our hands,
the production of RN! from isolated proximal tubules obtained
from SOR or rats with BUO was undetectable (data not shown).
Discussion
The leukocyte infiltration of the renal parenchyma in rats
with BUO is composed of macrophages, lymphocytes and
neutrophils [2, 3]. These invading cells have a significant role in
the hemodynamic alterations seen in rats with BUO. Specifi-
cally, they are associated with increased production of vaso-
constrictor substances such as leukotrienes [2] and thrombox-
ane A2 [3,9]. On the other hand, L-arginine has a role in
ameliorating the alterations in renal function and systemic
hypertension seen in rats with BUO [5]. We found that admin-
istration of L-arginine significantly increased GFR and ERPF
and decreased MAP in rats with unilateral release of BUO [5].
Published evidence indicates that macrophages metabolize
L-arginine to RN! including nitrite, nitrate, and NO [4]. We
examined the invasion of the renal parenchyma by circulating
leukocytes in rats with BUO; our purpose was to elucidate the
contribution of invading leukocytes to changes in plasma and
Fig. 2. Release of L-arginine from proximal tubules isolated from rats
of Group IV: sham-operated rats (0; SOR) (N = 5) and rats with
bilateral ureteral obstruction (; BUO) of 24 hours duration (N = 5) in
the absence (Basal) and presence of substrate (L-citrulline + L-aspar-
late). "P < 0.02 vs. SOR; < 0.02 vs. BUO-basal.
renal tissue levels of L-arginine and to the ability of proximal
tubules obtained from rats with BUO to synthesize L-arginine.
Three salient findings of the present study are: (1) rats with
BUO had lower plasma levels and lower renal tissue concen-
trations of L-arginine and lower excretion of URNI than SOR;
(2) prior total body irradiation in BUO rats to abolish the
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leukocyte infiltration of the renal parenchyma prevented the
decrease in plasma levels of L-arginine observed in nonirradi-
ated BUO rats, and (3) proximal tubules isolated from rats with
BUO released less L-arginine than those obtained from SOR.
The lower plasma and renal tissue levels of L-arginine seen in
rats with BUO have several possible origins: decreased absorp-
tion of L-arginine, increased utilization of L-arginine, or de-
creased synthesis of L-arginine.
An endogenous antagonist of L-arginine has been identified in
uremia and it has been suggested that it may competitively
inhibit the synthesis of NO from L-arginine in this setting [18].
Our studies in nephrectomized rats argue against this possibil-
ity. Plasma levels of L-arginine were greater after 4 or 24 hours
of uremia induced by total nephrectomy than at baseline,
suggesting that absence of renal parenchyma does not neces-
sarily result in lower plasma levels of L-arginine. This suggests
that organs other than the kidney can maintain the plasma levels
of L-arginine constant and that the accumulation of an endog-
enous inhibitor of NO after bilateral nephrectomy does not
affect the availability of L-arginine, the substrate for NO
synthesis. This contrasts with the significantly lower plasma
levels of L-arginine seen in rats with renal failure due to BUO
of 24 hours duration, in which absence of excretory function
with preservation of some endocrine renal function did not
maintain normal plasma levels of the amino acid. This obser-
vation led us to postulate that activation of the immune system
seen in rats with BUO, but not in rats with bilateral nephrec-
tomy, may have a role in inhibiting expected extrarenal increase
in the synthesis of L-arginine. It remains to be determined
whether the effect of the immune system in preventing extra-
renal tissues from maintaining normal plasma levels of L-
arginine is mediated either through inhibition of extrarenal
release of L-arginine, hepatic activation of arginase, or both.
Since the increase in plasma levels of urea was similar after 24
hours in nephrectomized rats and in BUO rats, extrarenal
inhibition of L-arginine release may have a more important role
than activation of the liver arginase.
The importance of activation of the immune system in
mediating the changes in plasma and tissue levels of L-arginine
in rats with BUO is suggested by the effect of total body
irradiation, a maneuver that decreased the infiltration of the
kidney by leukocytes [2, 3]. Total body irradiation prevented
the reduction in plasma and tissue levels of L-arginine (Table 2).
Moreover, it increased significantly the tissue levels of L-
arginine in rats with BUO but not in SOR, suggesting that a
non-specific effect of irradiation cannot account for this effect.
However, the exact mechanism responsible remains to be
determined.
Our data do not support an increase in L-arginine utilization
by inflammatory cells through the nitric oxide synthase path-
way as the reason for the low plasma and renal tissue levels of
L-arginine seen in rats with BUO. If invading leukocytes had
increased their use of L-arginine through this metabolic path-
way, we should have seen a significant increase in URN! in rats
with BUO. However, this was not the case. Our results do not
exclude a possible change in the activity of the enzymes of
the urea cycle that could have affected the plasma levels of L-
arginine. Currently we are examining this possibility by study-
ing the changes in L-ornithine metabolism in rats with BUO.
Total body irradiation lowered the excretion of reactive
nitrogen intermediates in the urine of sham-operated rats. Since
this maneuver decreases significantly the formation of bone
marrow-derived leukocytes [3] it is plausible to assume that the
decrease in URNI observed in irradiated sham-operated and
BUO rats reflects impairment of basal metabolism of L-arginine
through the NO pathway by immune cells (Fig. 1). On the other
hand, total body irradiation did not abolish URNI completely
in either SOR or rats with BUO, suggesting metabolism of L-
arginine through the NO pathway in cells other than those of the
immune system, most likely vascular cells [19] and/or cells of
the central nervous system [20].
Our data raise the possibility of an interaction among invad-
ing leukocytes, proximal tubular cells (where L-arginine is
synthesized in the kidney), and any or all other extrarenal
tissues known to be active in the synthesis and/or release of
L-arginine (that is, liver, muscle, brain) such that the final effect
is a reduction in plasma levels of L-arginine. We examined the
synthesis of L-arginine by proximal tubules in the presence and
absence of its precursors, L-citrulline and L-aspartate. Proxi-
mal tubules obtained from rats with BUO synthesized signifi-
cantly less L-arginine under the conditions studied, suggesting
altered ability of proximal tubules to maintain normal synthesis
of this amino acid. However, since the total absence of renal
tissue did not decrease plasma levels of L-arginine our results
suggest that the stimuli that inhibit L-arginine release by
proximal tubules from rats with BUO may also affect extrarenal
tissues. In other words, if only proximal tubules were under the
influence of that inhibition, extrarenal structures would have
maintained normal plasma levels of L-arginine. The inhibition
of L-arginine release by renal and extrarenal structures in rats
with BUO was blunted by irradiation, suggesting a key role of
the immune system in mediating this effect (Table 2). We
propose that activation of the inflammatory system, as seen in
rats with BUO, is responsible for the impaired capability of
renal and extrarenal structures to release L-arginine. Interest-
ingly, the decreased ability of proximal tubules isolated from
BUO rats to synthesize L-arginine was somewhat restored by
incubation with physiological concentrations of L-citrulline in
the presence of pharmacological concentrations of L-aspartate,
a nitrogen donor for L-arginine synthesis. This effect suggests
that the impaired ability of proximal tubules of rats with BUO to
synthesize L-arginine is more likely due to a metabolic inhibi-
tion than to structural damage. The exact nature of this meta-
bolic inhibition remains to be elucidated.
There are differences among models of renal disease charac-
terized by leukocyte infiltration. BUO is characterized by a
reduction in GFR and ERPF, and an increase in systemic blood
pressure and renal vascular resistance [5]. In nephrotoxic
nephritis, a normotensive model of renal disease with leukocyte
invasion of the kidneys, the salient feature is proteinuria. In
contrast to our results of decreased nitrate and nitrite excretion
in the urine of rats with BUO, Cattell, Cook and Moncada [21]
reported significantly greater excretion of nitrite in the urine of
rats with immune-mediated nephritis. Due to differences in the
model of disease examined, and the gender and strain of rats
used, it is difficult to compare the two studies. The conflicting
results obtained suggest that the mechanism(s) and/or patho-
physiological relevance of leukocyte activation and infiltration
to the renal parenchyma may differ in the two models. Thus, it
is possible that the event responsible for leukocyte activation
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may determine if the activated cells increase L-arginine utiliza-
tion, in which case lower plasma levels of L-arginine would be
accompanied by greater urine excretion of RN!. Alternatively,
when the predominant effect of inflammatory activation is
decreased synthesis of L-arginine by renal and extrarenal
structures, lower plasma levels of L-arginine may be accompa-
nied by lower excretion of URN!. !n both scenarios the avail-
ability of L-arginine for NO synthesis by cells other than
macrophages would be impaired. Therefore, it is possible that
in immune-induced nephritis there is increased consumption of
L-arginine through the NO pathway of macrophages whereas in
mechanically-induced nephropathy (BUO model) the opposite
mechanism predominates. The explanation of how two models
of renal disease characterized by leukocyte infiltration affect
this metabolic pathway so differently is not readily apparent.
The present demonstration of reduced synthesis of L-arginine
by proximal tubules from rats with BUO is in agreement with
previous reports from this laboratory indicating significant
depression in the metabolic function of this and other segments
of the nephron during ureteral obstruction, as evidenced by
significant decrease in gluconeogenesis and ammonia synthesis
[Reviewed in 22].
!n summary, we report low plasma levels and low renal tissue
levels of L-arginine and low excretion of URNI in rats with
BUO. This defect appears to be mediated by the infiltration of
the renal parenchyma by circulating leukocytes which may
diminish the synthesis of L-arginine in renal and extrarenal
tissues.
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